
ludovic vallier
@VallierLab
Followers
4K
Following
3K
Media
139
Statuses
2K
Liver biologist, human pluripotent stem cells, cell based therapy believer, opinions are my own.
Joined August 2013
New paper from @VallierLab is online. "Acquisition of epithelial plasticity in human chronic liver diseases". Amazing work from @chrisgrbbn and @VasileiosGalan in collaboration with @imohorianu and Mike Alison. Few key points: .1/.
link.springer.com
Nature - Single-cell RNA sequencing and 3D imaging have revealed the cellular changes and structural reorganization that occur during the progression of human chronic liver disease and as the liver...
9
27
137
So, we (Dylan Liabeuf and Anastasiia Maksiuk) are organising the first Berlin symposium on organoids. The objective is to bring together the Berlin organoid community and to develop further interactions. Info:.Free registration:.
bihealth.org
Registration: Berlin Organoid Symposium - Berliner Institut für Gesundheitsforschung - Charité und Max-Delbrück-Centrum
0
5
17
RT @mleptin: Very promising news on the next seven-year EU budget, with a proposed substantial increase for Horizon Europe including the ER….
research-and-innovation.ec.europa.eu
Research and innovation news alert: As part of the next long-term EU budget 2028-2034, the Commission is proposing to double the budget of the research and innovation framework programme to €175...
0
48
0
The latest paper @VallierLab is now online. This tour de force from the amazing Laetitia Pinte (supervised by @martavilagonz ) uncover the function of EHF in the lung (not a liver story!) epithelium using hiPSCs, genome editing, and lung organoids.
journals.biologists.com
Editor's choice: In human airway epithelial cells, the loss of EHF protein enhances CFTR activity, leads to transcriptomic changes in basal cells, increases transepithelial electrical resistance and...
0
4
12
Results for ERC advanced grants. UK is back in the lead with 56 funded projects and Germany is second with 35 grants!. Success rate 11%. Hopefully the ERC budget will significantly increase to attract scientists from outside EU.
erc.europa.eu
The European Research Council (ERC) today announced the winners of its latest Advanced Grant competition. The funding, worth in total €721 million, will go to 281 leading researchers across Europe....
0
1
12
RT @hepaticcellnews: Drs. Yong He, Yingfen Chen, and Frank Tacke #review current data related to the immunological mechanisms of #MASLD.….
0
1
0
RT @SNakanoh: My single-author review is open in Special issue: Extraembryonic tissue in DB - covers issues on human amnion & extraembryoni….
0
1
0
RT @RSeguiLab: A great collaborative effort from @RSeguiLab’s PhD students Silvio Traba and Lucas Bacigalupo, working with @VallierLab ! 🎉🔬….
0
1
0
RT @RSeguiLab: Thrilled to announce a major milestone for our lab @ifibyne @Exactas_UBA — our paper on the glucocorticoid receptor's role i….
0
1
0
RT @SomiteAi: Somite is building the blueprints to create any cell type for any person. We call it DeltaStem, our foundation model for the….
0
10
0
RT @RSeguiLab: Lab gathering today to celebrate a big milestone—our paper on the glucocorticoid receptor’s role in early pancreas developme….
0
2
0
Don't miss the "4th International Symposium on Regenerative Hepatology". Amsterdam May 6, 2024. Excellent program featuring hepatocyte organoid expansion, hepatic cellular plasticity in regeneration, microRNAs, and gene therapy for liver disease etc.
regenerativehepatology.com
1
3
10
RT @LiabeufDylan: Very cool @Nature Rev. Gastro/hepato. Nice job, Carmen, @MassimoPinzani and Ludovic!. #Celltherapy for #liver disorders:….
0
1
0
Our review Cell therapy for liver disorders: past, present and future is now available in Nature Rev. Gastroenterology & Hepatology. The development of such therapies remain a major objective for @vallierlab.bsky.social.
nature.com
Nature Reviews Gastroenterology & Hepatology - The burden of liver disorders increases worldwide as does the necessity for new treatments. This Review discusses cell therapy as an alternative...
0
0
5
RT @celltherapynews: A new #review from the @VallierLab at @ChariteBerlin discusses the advantages and drawbacks of distinct cell sources a….
0
1
0
You can still register to the EMBO Workshop Liver and pancreas in metabolic disease: from pathways to therapies Sant Feliu de Guíxols (Girona), Spain, 2 – 4 April 2025. Great science in a beautiful place.
meetings.embo.org
The liver and pancreas arise from a common developmental origin and are controlled by shared gene regulatory programs.These organs are central to two of the most common and devastating metabolic dise…
0
6
13